Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients
NCT00455364Phase 4Terminated
- Sponsor
- University of Chicago
- Start
- Apr 2007
- Primary completion
- Apr 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of voriconazole in fungal infection, sponsored by University of Chicago. Started Apr 2007; status: terminated.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00455364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455364.